VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $314,000 | -20.7% | 1,759 | -1.4% | 0.01% | -27.3% |
| Q2 2015 | $396,000 | +8.8% | 1,784 | -2.6% | 0.01% | +10.0% |
| Q1 2015 | $364,000 | +14.1% | 1,831 | -17.8% | 0.01% | +11.1% |
| Q4 2014 | $319,000 | +0.9% | 2,228 | -7.6% | 0.01% | -10.0% |
| Q3 2014 | $316,000 | -2.2% | 2,412 | -5.7% | 0.01% | 0.0% |
| Q2 2014 | $323,000 | -75.2% | 2,559 | -74.1% | 0.01% | -75.6% |
| Q1 2014 | $1,301,000 | +18.5% | 9,867 | +5.5% | 0.04% | +17.1% |
| Q4 2013 | $1,098,000 | +13.2% | 9,354 | +0.6% | 0.04% | +2.9% |
| Q3 2013 | $970,000 | +21.2% | 9,299 | 0.0% | 0.03% | +13.3% |
| Q2 2013 | $800,000 | – | 9,299 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |